COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 2316: Articles 23151-23160  | Next

Relation of Doubling Time and Reproduction Number with Testing Rate for Corona Infections in India
Indrayan, A., Mishra, A.
10.1101/2020.08.29.20184283 — Posted: 2020-09-02 Discussion: Onsite
Are COVID-19 proximity tracing apps working under real-world conditions? Indicator development and assessment of drivers for app (non-)use
von Wyl, V., Hoeglinger, M., Sieber, C., Kaufmann, M., Moser, A., Serra-Burriel, M., Ballouz, T., Menges, D., Frei, A., Puhan, M.
10.1101/2020.08.29.20184382 — Posted: 2020-09-02
The Uncertain COVID-19 Spread Pattern in India: A Statistical Analysis of the Current Situation
Baruah, H. K.
10.1101/2020.08.30.20184598 — Posted: 2020-09-02
Entry screening and multi-layer mitigation of COVID-19 cases for a safe university reopening
Elbanna, A., Wong, G. N., Weiner, Z. J., Wang, T., Zhang, H., Liu, Z., Tkachenko, A. V., Maslov, S., Goldenfeld, N.
10.1101/2020.08.29.20184473 — Posted: 2020-09-02
Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study
Ulyte, A., Radtke, T., Abela, I., Haile, S. H., Braun, J., Jung, R., Berger, C., Trkola, A., Fehr, J., Puhan, M. A., Kriemler, S.
10.1101/2020.08.30.20184671 — Posted: 2020-09-02
One Study of COVID-19 Spreading at The United States - Brazil - Colombia
Cirilo, E. R., Candezano, M., Natti, P., Romeiro, N., Polo, J.
10.1101/2020.08.29.20184465 — Posted: 2020-09-02
Modeling the combined effect of digital exposure notification and non-pharmaceutical interventions on the COVID-19 epidemic in Washington state
Abueg, M., Hinch, R., Wu, N., Liu, L., Probert, W. J. M., Wu, A., Eastham, P., Shafi, Y., Rosencrantz, M., Dikovsky, M., Cheng, Z., Nurtay, A., Abeler-Dörner, L., Bonsall, D. G., McConnell, M. V., O'Banion, S., Fraser, C.
10.1101/2020.08.29.20184135 — Posted: 2020-09-02
Analyzing inherent biases in SARS-CoV-2 PCR and serological epidemiologic metrics
Makhoul, M., Abou-Hijleh, F., Seedat, S., Mumtaz, G. R., Chemaitelly, H., Ayoub, H., Abu-Raddad, L. J.
10.1101/2020.08.30.20184705 — Posted: 2020-09-02
The methodological quality of COVID-19 systematic reviews is low, except for Cochrane reviews: a meta-epidemiological study
KATAOKA, Y., Oide, S., Ariie, T., Tsujimoto, Y., Furukawa, T. A.
10.1101/2020.08.28.20184077 — Posted: 2020-09-02
The evolution of Covid-19 in Italy during the Summer 2020: analysis and interpretation of an unpredicted rest period
De Natale, G., De Natale, L., Troise, C., Somma, R., Marchitelli, V., Coviello, A., Holmberg, K.
10.1101/2020.08.29.20184127 — Posted: 2020-09-02 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).